Trump eyes escalating tariffs on generics to push U.S. production onshore
TL;DR Summary
Trump outlined a phased tariff plan on imported generic drugs: zero tariffs for two years starting Aug 1, 2026, then a 100% levy in Aug 2028 and 200% a year later, while tariffs on patented drugs stay the same. The move aims to force generic manufacturers to relocate production to the U.S. as part of a broader push to lower drug prices and reshape supply chains, amid ongoing dynamics with India and China in pharma.
- Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production CNBC
- Trump Sets 100% Tariff on Generic Drugs With Two-Year Delay Bloomberg.com
- U.S. Will Tariff Generic Drugs in 2028, Trump Says WSJ
- Trump says he will impose tariffs on generic drugs starting in August 2028 Politico
- Trump says generic drugs to face no US tariffs for 2 years, then 100% and 200% tariffs later Reuters
Reading Insights
Total Reads
1
Unique Readers
5
Time Saved
2 min
vs 2 min read
Condensed
80%
382 → 75 words
Want the full story? Read the original article
Read on CNBC